Skip to main content

Radical journal gathers support

The scientific community appears to be fighting to convince Elsevier to continue to publish its only non-peer-reviewed journal, after the publisher began to linkurl:consider installing a traditional peer review system;https://www.the-scientist.com/blog/display/57121/ when the journal published a controversial paper supporting the arguments of AIDS deniers. Image: flicker/linkurl:meviola;https://www.flickr.com/photos/69659670@N00/ Despite the uproar that article created, the editor-in-chief of lin

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
The scientific community appears to be fighting to convince Elsevier to continue to publish its only non-peer-reviewed journal, after the publisher began to linkurl:consider installing a traditional peer review system;https://www.the-scientist.com/blog/display/57121/ when the journal published a controversial paper supporting the arguments of AIDS deniers.
Image: flicker/linkurl:meviola;https://www.flickr.com/photos/69659670@N00/
Despite the uproar that article created, the editor-in-chief of linkurl:Medical Hypotheses;https://www.elsevier.com/wps/find/journaldescription.cws_home/623059/description has received more than 150 letters of support for the journal's non-traditional publishing model, in which papers are chosen by the editor-in-chief, linkurl:Bruce Charlton.;https://www.buckingham.ac.uk/publicity/dofe/charlton.html "Medical Hypotheses has become an important vehicle for publishing exciting new ideas and information that is helping to shape the directions of medical research," linkurl:wrote;https://medicalhypotheses.blogspot.com/2010/02/medical-hypotheses-authors-letters-of.html linkurl:Paul W. Sherman;https://www.nbb.cornell.edu/sherman.shtml of Cornell University in New York. "Cancelling the journal, or massively altering its focus and editorial policies, would potentially deprive both the medical and biological communities of their only existing forum for interaction." Charlton, who has forwarded the majority of the letters on to Elsevier, is vying to keep the journal in its current form or have it discontinued altogether and not transformed into "an imposter having the same name," he wrote in an email to The Scientist. "I found it inspiring to realize that so many would take the trouble to write, and often at length," Charlton wrote. "These letters strongly reinforced my conviction that Medical Hypotheses, in its 35 years, has been a very worthwhile journal; one whose existence has made a significant and positive difference to the work of many scientists and scholars." The journal's editorial board also recently wrote to the publisher saying it did not approve of the proposals to introduce a peer-review system and exclude papers on controversial topics, linkurl:the Times Higher Education reported.;https://www.timeshighereducation.co.uk/story.asp?sectioncode=26&storycode=410489 Elsevier has not yet responded to the letter, Tom Reller, director of Corporate Relations at Elsevier, wrote in an email to The Scientist, and the fate of the journal is still undecided.
**__Related stories:__***linkurl:Radical journal's fate at risk;https://www.the-scientist.com/blog/display/57121/
[27th January 2010]*linkurl:Elsevier published 6 fake journals;https://www.the-scientist.com/blog/display/55679/
[7th May 2009]*linkurl:Journal plays with peer review;https://www.the-scientist.com/blog/display/55394/
[3rd February 2009]*linkurl:Tackling peer review bias;https://www.the-scientist.com/blog/display/54893/
[28th July 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays